biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > BTI:TSXV: Announces $200,000 Non-Brokered Private Placement

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Jan 29, 2021 8:20pm

138 Views

Post# 32426793

RE:RE:RE:RE:RE:RE:BTI:TSXV: Announces $200,000 Non-Brokered Private Placement

I'm sure this individual and the company wouldn't be that naive and stupid to do this with the possibility of insider trading. It may be quite simply this individual wanted a big position ASAP, didn't want to buy on the open market so as to drive the price way up since this company has no volume and is quite illiquid and was willing to pay a premium.

<< Previous

Bullboard Posts

Next >>

Full Circle Lithium goes global with its battery fire-fighter